ResultsIQ

ResultsIQ › Latest results › MPS Limited

MPS Limited Q1 FY27 results deck summary

NSE: MPSLTD · BSE: 532440

Results deck of 21 Jul 2026, summarised by AI from the filing.

MPS reported record Q1 FY27 revenue of ₹22,424 lakh, EBITDA of ₹7,696 lakh and PAT of ₹5,039 lakh, and reiterated FY27 EBITDA guidance of ₹300+ cr.

Key takeaways

  1. FY27 guidance Management reiterated FY27 EBITDA guidance of ₹300+ cr, a mark it expects to clear comfortably.
  2. Margin expansion EBITDA margin rose to 34.32% in Q1 FY27 from 32.90% in Q4 FY26.
  3. Education growth Education revenue grew 42.21% YoY to ₹7,341 lakh, with Unbound Medicine's first full quarter adding recurring healthcare revenue.
  4. AJE reset AJE is resetting by design, weighing on reported revenue growth.

Original filing on BSE

MPS Limited Q1 FY27 results

As filed: Revenue ₹224 cr (+21% year on year), EBITDA ₹77.0 cr (+51% year on year), PAT ₹50.4 cr (+44% year on year), EBITDA margin 34.3% (+690 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹205 cr (+13% year on year), EBITDA ₹67.5 cr (+21% year on year), PAT ₹47.0 cr (0% year on year), EBITDA margin 32.9% (+214 bps). Score 54 of 100, In line with trend. Revenue and profit growth were below the company's own trend; EBITDA growth was above it. EBITDA margin rose 214 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +11.5% in 30 days (Nifty 500: +1.0%).
  • Q3 FY26: Revenue ₹182 cr (−2% year on year), EBITDA ₹57.6 cr (−4% year on year), PAT ₹35.5 cr (−3% year on year), EBITDA margin 31.6% (−71 bps). Score 27 of 100, Below trend. Revenue and EBITDA growth were well below the company's own trend; profit before exceptional items growth was below it. EBITDA margin fell 71 bps year on year. Revenue fell 6% from last quarter. Share price after the results: −22.2% in 30 days (Nifty 500: +0.4%).
  • Q2 FY26: Revenue ₹194 cr (+9% year on year), EBITDA ₹60.0 cr (+13% year on year), PAT ₹55.0 cr (+17% year on year), EBITDA margin 30.9% (+115 bps). Score 46 of 100, In line with trend. Revenue growth was below the company's own trend; EBITDA and profit before exceptional items growth were in line with it. EBITDA margin rose 115 bps year on year. Profit before exceptional items rose ₹8.0 cr on a year ago, more than the ₹7.0 cr it added the year before. Share price after the results: −7.6% in 28 days (Nifty 500: +1.3%).
  • Q1 FY26: Revenue ₹186 cr (+3% year on year), EBITDA ₹51.0 cr (+24% year on year), PAT ₹35.0 cr (+35% year on year), EBITDA margin 27.4% (+477 bps). Score 50 of 100, In line with trend. Revenue growth was well below the company's own trend; EBITDA and profit growth were above it. EBITDA margin rose 477 bps year on year. Profit fell 26% from last quarter. Share price after the results: −19.6% in 29 days (Nifty 500: −4.4%).
  • Q4 FY25: Revenue ₹182 cr (+22% year on year), EBITDA ₹56.0 cr (+33% year on year), PAT ₹47.0 cr (+62% year on year), EBITDA margin 30.8% (+258 bps). Score 80 of 100, Above trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 258 bps year on year. Revenue rose ₹33.0 cr on a year ago, more than the ₹22.0 cr it added the year before. Share price after the results: +8.5% in 30 days (Nifty 500: +3.7%).
  • Q3 FY25: Revenue ₹186 cr (+39% year on year), EBITDA ₹60.0 cr (+33% year on year), PAT ₹41.0 cr (+37% year on year), EBITDA margin 32.3% (−132 bps). Score 74 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well above it. EBITDA margin fell 132 bps year on year. Consolidated profit +37% but standalone -9%.
  • Q2 FY25: Revenue ₹178 cr (+37% year on year), EBITDA ₹53.0 cr (+29% year on year), PAT ₹35.0 cr (+17% year on year), EBITDA margin 29.8% (−176 bps). Score 67 of 100, Above trend. EBITDA margin fell 176 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

MPS Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.